“A.G.E.S. Fall Conference” on BrightU: How newborn DNA sequencing paves the way for a lifetime of medical surveillance

• On Day 2 of “A.G.E.S. Fall Conference Docuseries,” airing on Feb. 27, Leah Wilson shared that a national genetic database of newborns is being proposed, with pilot programs funded by the NIH to replace traditional newborn screening with full DNA sequencing for every American infant.
• This shifts the purpose from detecting treatable diseases to assigning lifelong genetic risk scores, enabling a system of medical surveillance where compliance with state-recommended protocols can be tracked.
• The initiative is closely tied to the gene therapy industry, creating a pipeline to route newborns flagged by sequencing toward expensive and sometimes experimental genetic treatments, based on probabilistic rather than determinative data.
• The consequences include loss of bodily sovereignty and genetic determinism, potentially affecting insurance, creating “health scores” and causing decades of unnecessary medicalization and fear for families based on risk predictions.
• Legislation (HR 4709) is advancing to fund the infrastructure for this system, mirroring global models, making immediate public opposition and demands for an opt-in, fully informed consent model critical to halt the program.

Brighteon University is streaming an episode a day of “A.G.E.S. Fall Conference Docuseries” from Feb. 21 to March 4, and a replay of all 10 episodes on March 5 to 8. Register here to dive into the masterclass in natural, holistic healing you’ve been searching for and start your journey to total wellness.

On Day 2 of “A.G.E.S. Fall Conference Docuseries,” airing on Feb. 22, health freedom leader Leah Wilson detailed how a quiet but seismic shift is underway. The National Institutes of Health (NIH) has allocated $14.4 million to pilot programs that would replace traditional newborn biomarker tests with full DNA sequencing. The goal? To create a national genetic database of every American newborn.

Imagine a world where your child’s biological blueprint is cataloged by the state before they take their first breath, not to heal, but to track, control and commodify. This is not dystopian fiction. It’s the alarming reality unfolding in the United States right now, as health freedom advocates sound the alarm on a sweeping initiative to integrate whole genome sequencing into compulsory newborn screening programs.

“This is about building trust as much as building science,” Wilson warned, quoting the initiative’s own language. But behind the promise of “progress” lies a far darker agenda: the systematic erosion of bodily sovereignty and the funneling of healthy infants into a lucrative, risk-laden pipeline of gene therapies and lifelong medical surveillance.

From screening to surveillance

Currently, newborn screening is a compulsory process in all 50 states, testing for 30 to 75 biomarkers. While some conditions are actionable, the leap to whole genome sequencing changes everything. It moves from detecting actual disease to assigning probabilistic risk scores, predicting futures based on genes that scientists admit are only 3% to 10% determinative for most outcomes.

This genetic data, Wilson explained, won’t stay in a doctor’s office. It will feed into a federal database, enabling unprecedented tracking of “compliance with medical protocols.” She pointed to existing cystic fibrosis surveillance as a precursor: once diagnosed, a child’s DNA enters a national system that monitors whether families follow state-recommended treatments. With whole genome sequencing, every child becomes a tracked entity, their biological code used to influence insurance eligibility, access to education and even social credit-style “health scores” hidden in digital medical records.

The push for sequencing is inextricably linked to the booming gene therapy industry. As noted by BrightU.AI‘s Enoch, gene therapy aims to treat or cure genetic diseases by introducing functional genes into a patient’s cells. It can be divided into two main types: somatic therapy, which targets body cells and is not inherited, and germline therapy, which targets reproductive cells and can be passed to offspring.

Wilson highlighted the recent addition of spinal muscular atrophy (SMA) to the newborn screening list. Babies who test positive are immediately routed toward Zolgensma, a $2.1 million one-time gene therapy, despite the foundational research for the treatment being retracted after it was revealed that only one of seven test mice survived. “They are looking at the presence of a gene as absolutely determinative when we know it’s a probability,” Wilson stated. “To call this determinative is like sorcery.” The narrative of “miracle cures” for rare diseases, she argues, is a Trojan horse to normalize experimental, profit-driven interventions for healthy babies flagged by sequencing.

A future of genetic determinism and control

The implications are staggering. Parents shared stories with Wilson of being told their newborns would “eventually get leukemia” or that their hearts would “eventually fail,” leading to decades of unnecessary fear and medicalization. One mother reported that a positive screen now obligates her family to disclose the result on life insurance applications, affecting premiums and coverage.

With states like Florida already allocating $20 million to sequence 100,000 babies and a bill in Congress (HR 4709) seeking to fund the infrastructure for a national genomic database, the system is being built at breakneck speed. “They are on track to have every individual in their entire country in a genomic database by 2048,” Wilson said, referring to China’s model. “This is what it looks like for the U.S. to enter that race.”

Wilson ended with an urgent plea: this is a pivotal moment to halt the genetic panopticon. She encouraged viewers to scan a QR code and email their congressional representatives to oppose HR 4709 and demand that whole genome sequencing remain an opt-in, fully informed choice—not a compulsory program disguised as public health.

“We have spent the last year uncovering the devastation of the over-medicalization of children,” she declared. “I will be damned if we allow something like this to proceed under a veil of darkness on our watch.” The battle for health freedom has entered a new, genetic frontier. The question is: Will we allow our children’s DNA to become a tool of state and corporate control, or will we defend their right to an un-cataloged, sovereign future?

Want to learn more?

The A.G.E.S. doctors have come together not to sell you fear, but to hand you the tools, knowledge and confidence to become the architect of your own vitality. If you are ready to stop collecting fragments of the solution, it’s time to own the masterplan. Purchase the “A.G.E.S. Fall Conference Docuseries” full package here.

Upon purchase, you will receive instant and unlimited access to 15 exclusive, expert-led conference videos, 7 A.G.E.S Family Q&A session videos, downloadable presentation PDFs and full transcription PDF for every video.

BrighteonUniversity.com 1

BrighteonUniversity.com 2

BrightU.com